Seeking Alpha

TRADE ALERT: Sell Unity Software, Case Study In Discipline; 50%+ Return In 7 Months

Back in February, roughly 7 months ago, I recommended Unity to paying subscribers.This was a tough pick to make. In the weeks ahead, the market would have to deal with the onslaught of Liberation ...
Nasdaq

UNITY Biotechnology Doses First Patient in ENVISION, the Phase 2 Study of UBX1325 in Wet Age-Related Macular Degeneration

SOUTH SAN FRANCISCO, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ...
Nasdaq

UNITY Biotechnology to Present 36-Week Data from ASPIRE Phase 2B Study at ARVO 2025 Annual Meeting

UNITY Biotechnology, Inc. has announced that it will present data from its ASPIRE Phase 2B study on its senolytic candidate, UBX1325, targeting diabetic macular edema at the upcoming ARVO 2025 Annual ...
Pocket Gamer.Biz

Unity dominates web games but performance-optimised engines have key advantages according to a new study

A new study into the engines powering the most successful web games has revealed the overwhelming dominance of Unity, but highlights a critical trade-off between its powerful ecosystem and the ...